Effect of Extended-Release Oxymorphone Hydrochloride (Opana ER), Taken Fasting Versus With Food, on Cognitive Functioning in Opioid-Tolerant Subjects: a Randomized, Single-Blinded, Cross-Over Study.
Phase of Trial: Phase IV
Latest Information Update: 08 Sep 2011
At a glance
- Drugs Oxymorphone (Primary)
- Indications Pain
- Focus Adverse reactions
- 29 Aug 2010 Primary endpoint 'Cambridge Neuropsychological Test Automated Battery - Rapid Visual Information Processing Test score' met, according to an abstract presented at the 13th World Congress on Pain.
- 29 Aug 2010 Results presented in an abstract at the 13th World Congress on Pain.
- 29 Aug 2010 Status changed from recruiting to completed, based on an abstract presented at the 13th World Congress on Pain.